More patients in the higher Gd-IgA1 group showed CKD progression than those in the lower Gd-IgA1 group (40.2% in the higher Gd-IgA1 group versus 20.9% in the lower Gd-IgA1 group, p = 0.002). This evidence concerns the gene IGHA1 and chronic kidney disease.